Published in Oncology Business Week, February 10th, 2008
Under the agreement, Alfacell has granted BL&H exclusive rights in the defined territory for the marketing, sales and distribution of ONCONASE. Alfacell has received an up-front fee of $100,000 and is eligible for milestone payments based...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.